Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New spironolactone formulation imparts improved bioavailability, clinical response

Aug. 13, 1997

TNP-470 for treatment of mesangial proliferative glomerulonephritis

Aug. 11, 1997

Medtronic's therapy for urinary incontinence recommended for approval by FDA panel

Aug. 8, 1997

Synsorb Biotech begins phase III trial for Synsorb Pk

July 25, 1997

FK-143: promising new BPH therapy

July 17, 1997

RPR launches room-temperature formulation of DDAVP

July 16, 1997

Selective alpha1a-adrenoceptor blockers described by Merck & Co.

July 10, 1997

Natural products for the treatment of BPH

July 9, 1997

Agents for BPH claimed by Merck & Co.

July 8, 1997

Hemodialyzer efficacy established in patients

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...